The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.

Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...

Merck & Co’s CEO Kenneth Frazier has said the pharma industry ... 80,000 of those people have a chance to live a longer better life.” He also noted the work that his company has done in ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... He also pointed to Winrevair, a medicine used to treat a rare and life-threatening lung condition that was approved by the Food and Drug ...

German pharmaceutical company Merck ... CEO Stefan Oschmann. Oschmann said: “I cordially thank Constantin Birnstiel for his engagement and the results achieved in positioning Merck as a science ...